Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells
A Del Fattore, R Luciano, R Saracino… - Expert opinion on …, 2015 - Taylor & Francis
Background: Malignant glial tumors, including glioblastoma multiforme, account for 15–20%
of pediatric CNS malignancies. They are most resistant to therapy and are associated with a …
of pediatric CNS malignancies. They are most resistant to therapy and are associated with a …
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
CD Porada, G Almeida-Porada - Advanced drug delivery reviews, 2010 - Elsevier
Mesenchymal stem cells (MSCs) possess a set of several fairly unique properties which
make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles …
make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles …
Porcine induced pluripotent stem cells produce chimeric offspring
FD West, SL Terlouw, DJ Kwon, JL Mumaw… - Stem cells and …, 2010 - liebertpub.com
Ethical and moral issues rule out the use of human induced pluripotent stem cells (iPSCs) in
chimera studies that would determine the full extent of their reprogrammed state, instead …
chimera studies that would determine the full extent of their reprogrammed state, instead …
Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery
G Almeida-Porada, AJ Atala, CD Porada - Molecular Therapy-Methods & …, 2020 - cell.com
Mesenchymal stromal cells (MSCs) possess several fairly unique properties that, when
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …
[HTML][HTML] Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats
J Liu, H Zhang, Y Zhang, N Li, Y Wen, F Cao, H Ai… - Molecules and cells, 2014 - Elsevier
Premature ovarian failure (POF) is a long-term adverse effect of chemotherapy treatment.
However, current available treatment regimens are not optimal. Emerging evidence …
However, current available treatment regimens are not optimal. Emerging evidence …
Coculture of bone marrow mesenchymal stem cells and nucleus pulposus cells modulate gene expression profile without cell fusion
Study Design. Changes in gene expression profile and cell fusion of mesenchymal stem
cells (MSC) and nucleus pulposus cells (NPC) after coculture were analyzed. Objective. To …
cells (MSC) and nucleus pulposus cells (NPC) after coculture were analyzed. Objective. To …
Human embryonic stem cell–derived mesoderm-like epithelium transitions to mesenchymal progenitor cells
Human embryonic stem cells (hESC) have the potential to produce all of the cells in the
body. They are able to self-renew indefinitely, potentially making them a source for large …
body. They are able to self-renew indefinitely, potentially making them a source for large …
Directing systemic oncolytic viral delivery to tumors via carrier cells
H Nakashima, B Kaur, EA Chiocca - Cytokine & growth factor reviews, 2010 - Elsevier
The systemic administration of oncolytic virus (OV) is often inefficient due to clearance of the
virus by host defense mechanism and spurious targeting of non-cancer tissues through the …
virus by host defense mechanism and spurious targeting of non-cancer tissues through the …
Application of genetically modified and cloned pigs in translational research
H Matsunari, H Nagashima - Journal of Reproduction and …, 2009 - jstage.jst.go.jp
Pigs are increasingly being recognized as good large-animal models for translational
research, linking basic science to clinical applications in order to establish novel …
research, linking basic science to clinical applications in order to establish novel …
Generation of mouse induced pluripotent stem cells by protein transduction
C Nemes, E Varga, Z Polgar… - … Engineering Part C …, 2014 - liebertpub.com
Somatic cell reprogramming has generated enormous interest after the first report by
Yamanaka and his coworkers in 2006 on the generation of induced pluripotent stem cells …
Yamanaka and his coworkers in 2006 on the generation of induced pluripotent stem cells …